Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.
Xu K, Park D, Magis AT, Zhang J, Zhou W, Sica GL, Ramalingam SS, Curran WJ, Deng X.
Xu K, et al. Among authors: zhou w.
Mol Cancer. 2019 Apr 10;18(1):85. doi: 10.1186/s12943-019-1012-4.
Mol Cancer. 2019.
PMID: 30971271
Free PMC article.